Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Butanal | HCID 261 | — |
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Imidazole | HCID 795 | — |
| Reactant | 4-Bromopyridine | HCID 14268 | — |
| Reactant | Thionyl Chloride | HCID 24386 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Lithium | HCID 3028194 | — |
| Reactant | HCID 19831109 | HCID 19831109 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 14514400 | HCID 14514400 | — |
Reaction Steps
The initial material, 4-(1-chlorobutyl)-pyridine, necessary for this reaction is obtained by the following reaction sequence. Commercial 4-bromo-pyridine is converted, by halometal exchange, into the corresponding 4-lithium-pyridine compound. This lithium compound is converted, with butyraldehyde, into the corresponding secondary alcohol. The alcohol is then converted by reaction with thionyl chloride into 4-(1-chlorobutyl)pyridine. 0.68 g of imidazole is dissolved in 5 ml of dimethylformamide, 0.3 g of sodium hydride (80%) is added and stirred for 10 minutes at room temperature. A solution of 3.87 g of 4-(1-chlorobutyl)-pyridine in 4 ml of dimethylformamide is added to this solution and stirred for 24 hours at room temperature. Then it is poured into 100 ml of 10% hydrochloric acid and extracted with ethyl acetate. The aqueous phase is made alkaline with sodium hydroxide solution (pH 13) and extracted with methylene chloride. The methylene chloride solution is concentrated by evaporation in a vacuum and the residue is distilled on a bulb tube, boiling point: 170°-190° C./0.04 mbar. 0.3 g of 4-[1-(1-imidazolyl)-butyl]-pyridine is obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05021434 |
|---|
| Source dataset | uspto-grants-1991_06 |
|---|
| ORD ID | ord-2dc4d463732f4647accf0b0a8a4a0cef |
|---|
| Source note | uspto-grants-1991_06 |
|---|